Dr. Lindsay Ackerman
Claim this profileMedical Dermatology Specialists
Studies Psoriasis
Studies Eczema
4 reported clinical trials
5 drugs studied
Affiliated Hospitals
Clinical Trials Lindsay Ackerman is currently running
Ixekizumab + Tirzepatide
for Psoriasis
The main purpose of this study is to demonstrate that when participants with moderate to severe plaque psoriasis and obesity or overweight receive ixekizumab and tirzepatide concomitantly administered, participants see improvement in their psoriasis and achieve weight reduction compared to when receiving ixekizumab. Participation in this study includes up to 12 visits and could last up to 61 weeks including screening, open label treatment period, and post-treatment follow-up period.
Recruiting2 awards Phase 33 criteria
Eltrekibart
for Hidradenitis Suppurativa
This trial is testing a new medication called eltrekibart to find the most effective treatment for adults with moderate-to-severe hidradenitis suppurativa. The goal is to see if it can safely and effectively reduce symptoms by targeting inflammation pathways.
Recruiting0 awards Phase 25 criteria
More about Lindsay Ackerman
Clinical Trial Related1 year of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Lindsay Ackerman has experience with
- Lebrikizumab
- Eltrekitibart
- TAK-279
- Ixekizumab
- Tirzepatide
Breakdown of trials Lindsay Ackerman has run
Eczema
Bullous Dermatitis
Atopic Dermatitis
Hidradenitis Suppurativa
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lindsay Ackerman specialize in?
Lindsay Ackerman focuses on Psoriasis and Eczema. In particular, much of their work with Psoriasis has involved treating patients, or patients who are undergoing treatment.
Is Lindsay Ackerman currently recruiting for clinical trials?
Yes, Lindsay Ackerman is currently recruiting for 3 clinical trials in Phoenix Arizona. If you're interested in participating, you should apply.
Are there any treatments that Lindsay Ackerman has studied deeply?
Yes, Lindsay Ackerman has studied treatments such as Lebrikizumab, Eltrekitibart, TAK-279.
What is the best way to schedule an appointment with Lindsay Ackerman?
Apply for one of the trials that Lindsay Ackerman is conducting.
What is the office address of Lindsay Ackerman?
The office of Lindsay Ackerman is located at: Medical Dermatology Specialists, Phoenix, Arizona 85006 United States. This is the address for their practice at the Medical Dermatology Specialists.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.